Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice

The global morbidity of obesity and type 2 diabetes mellitus (T2DM) has dramatically increased. Insulin resistance is the most important pathogenesis and therapeutic target of T2DM. The traditional Chinese medicine formula Astragalus mongholicus powder (APF), consists of Astragalus mongholicus Bunge...

Full description

Bibliographic Details
Main Authors: Siyuan Xu, Bixian Ye, Jinlei Li, Yonghui Dou, Yuying Yu, Yifan Feng, Lexun Wang, David Chi-Cheong Wan, Xianglu Rong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.973927/full
_version_ 1811321443397402624
author Siyuan Xu
Bixian Ye
Jinlei Li
Yonghui Dou
Yuying Yu
Yifan Feng
Lexun Wang
David Chi-Cheong Wan
Xianglu Rong
author_facet Siyuan Xu
Bixian Ye
Jinlei Li
Yonghui Dou
Yuying Yu
Yifan Feng
Lexun Wang
David Chi-Cheong Wan
Xianglu Rong
author_sort Siyuan Xu
collection DOAJ
description The global morbidity of obesity and type 2 diabetes mellitus (T2DM) has dramatically increased. Insulin resistance is the most important pathogenesis and therapeutic target of T2DM. The traditional Chinese medicine formula Astragalus mongholicus powder (APF), consists of Astragalus mongholicus Bunge [Fabaceae], Pueraria montana (Lour.) Merr. [Fabaceae], and Morus alba L. [Moraceae] has a long history to be used to treat diabetes in ancient China. This work aims to investigate the effects of APF on diabetic mice and its underlying mechanism. Diabetic mice were induced by High-fat-diet (HFD) and streptozotocin (STZ). The body weight of mice and their plasma levels of glucose, insulin, leptin and lipids were examined. Reverse transcription-polymerase chain reaction, histology, and Western blot analysis were performed to validate the effects of APF on diabetic mice and investigate the underlying mechanism. APF reduced hyperglycemia, hyperinsulinemia, and hyerleptinemia and attenuate the progression of obesity and non-alcoholic fatty liver disease (NAFLD). However, these effects disappeared in leptin deficient ob/ob diabetic mice and STZ-induced insulin deficient type 1 diabetic mice. Destruction of either these hormones would abolish the therapeutic effects of APF. In addition, APF inhibited the protein expression of PTP1B suppressing insulin–leptin sensitivity, the gluconeogenic gene PEPCK, and the adipogenic gene FAS. Therefore, insulin–leptin sensitivity was normalized, and the gluconeogenic and adipogenic genes were suppressed. In conclusion, APF attenuated obesity, NAFLD, and T2DM by regulating the balance of adipoinsular axis in STZ + HFD induced T2DM mice.
first_indexed 2024-04-13T13:17:52Z
format Article
id doaj.art-e26bb5da4e7d4ef684dbc94d28f97a2a
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T13:17:52Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e26bb5da4e7d4ef684dbc94d28f97a2a2022-12-22T02:45:25ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-08-011310.3389/fphar.2022.973927973927Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic miceSiyuan Xu0Bixian Ye1Jinlei Li2Yonghui Dou3Yuying Yu4Yifan Feng5Lexun Wang6David Chi-Cheong Wan7Xianglu Rong8Key Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Ministry of Education of China, Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Nursing, Medical College of Jiaying University, Meizhou, ChinaSchool of Chinese Meteria Medica, Guangzhou University of Chinese Medicine, Guangzhou, ChinaSchool of Chinese Meteria Medica, Guangzhou University of Chinese Medicine, Guangzhou, ChinaKey Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Ministry of Education of China, Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, ChinaKey Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Ministry of Education of China, Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, ChinaKey Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Ministry of Education of China, Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, ChinaSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, ChinaKey Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Ministry of Education of China, Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, ChinaThe global morbidity of obesity and type 2 diabetes mellitus (T2DM) has dramatically increased. Insulin resistance is the most important pathogenesis and therapeutic target of T2DM. The traditional Chinese medicine formula Astragalus mongholicus powder (APF), consists of Astragalus mongholicus Bunge [Fabaceae], Pueraria montana (Lour.) Merr. [Fabaceae], and Morus alba L. [Moraceae] has a long history to be used to treat diabetes in ancient China. This work aims to investigate the effects of APF on diabetic mice and its underlying mechanism. Diabetic mice were induced by High-fat-diet (HFD) and streptozotocin (STZ). The body weight of mice and their plasma levels of glucose, insulin, leptin and lipids were examined. Reverse transcription-polymerase chain reaction, histology, and Western blot analysis were performed to validate the effects of APF on diabetic mice and investigate the underlying mechanism. APF reduced hyperglycemia, hyperinsulinemia, and hyerleptinemia and attenuate the progression of obesity and non-alcoholic fatty liver disease (NAFLD). However, these effects disappeared in leptin deficient ob/ob diabetic mice and STZ-induced insulin deficient type 1 diabetic mice. Destruction of either these hormones would abolish the therapeutic effects of APF. In addition, APF inhibited the protein expression of PTP1B suppressing insulin–leptin sensitivity, the gluconeogenic gene PEPCK, and the adipogenic gene FAS. Therefore, insulin–leptin sensitivity was normalized, and the gluconeogenic and adipogenic genes were suppressed. In conclusion, APF attenuated obesity, NAFLD, and T2DM by regulating the balance of adipoinsular axis in STZ + HFD induced T2DM mice.https://www.frontiersin.org/articles/10.3389/fphar.2022.973927/fullAstragalus mongholicus powdertype 2 diabetes mellitusinsulin resistanceadipoinsular axisleptin
spellingShingle Siyuan Xu
Bixian Ye
Jinlei Li
Yonghui Dou
Yuying Yu
Yifan Feng
Lexun Wang
David Chi-Cheong Wan
Xianglu Rong
Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
Frontiers in Pharmacology
Astragalus mongholicus powder
type 2 diabetes mellitus
insulin resistance
adipoinsular axis
leptin
title Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
title_full Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
title_fullStr Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
title_full_unstemmed Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
title_short Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
title_sort astragalus mongholicus powder a traditional chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice
topic Astragalus mongholicus powder
type 2 diabetes mellitus
insulin resistance
adipoinsular axis
leptin
url https://www.frontiersin.org/articles/10.3389/fphar.2022.973927/full
work_keys_str_mv AT siyuanxu astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT bixianye astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT jinleili astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT yonghuidou astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT yuyingyu astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT yifanfeng astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT lexunwang astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT davidchicheongwan astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice
AT xianglurong astragalusmongholicuspowderatraditionalchinesemedicineformulaamelioratetype2diabetesbyregulatingadipoinsularaxisindiabeticmice